Adherium Ltd - Asset Resilience Ratio
Adherium Ltd (ADR) has an Asset Resilience Ratio of 1.23% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read debt load of Adherium Ltd for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2017–2023)
This chart shows how Adherium Ltd's Asset Resilience Ratio has changed over time. See ADR net asset value for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Adherium Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market value of Adherium Ltd.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | AU$43.26K | 1.23% |
| Short-term Investments | AU$0.00 | 0% |
| Total Liquid Assets | AU$43.26K | 1.23% |
Asset Resilience Insights
- Limited Liquidity: Adherium Ltd maintains only 1.23% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Adherium Ltd Industry Peers by Asset Resilience Ratio
Compare Adherium Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Vitrolife AB
ST:VITR |
Medical Devices | 7.27% |
|
Medprin Regenerative Medical Technologies Co. Ltd.
SHE:301033 |
Medical Devices | 19.31% |
|
Tellgen Corp
SHE:300642 |
Medical Devices | 8.60% |
|
Lumos Diagnostics Holdings Ltd
AU:LDX |
Medical Devices | 9.40% |
|
T&R Biofab Co. Ltd
KQ:246710 |
Medical Devices | 0.12% |
|
Ok Biotech Co Ltd
TW:4155 |
Medical Devices | 0.32% |
|
Promimic AB
ST:PRO |
Medical Devices | 8.62% |
|
Memphasys Ltd
AU:MEM |
Medical Devices | 0.00% |
Annual Asset Resilience Ratio for Adherium Ltd (2017–2023)
The table below shows the annual Asset Resilience Ratio data for Adherium Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-06-30 | 71.58% | AU$9.08 Million ≈ $6.42 Million |
AU$12.68 Million ≈ $8.97 Million |
+9.67pp |
| 2022-06-30 | 61.91% | AU$5.28 Million ≈ $3.74 Million |
AU$8.53 Million ≈ $6.04 Million |
-26.21pp |
| 2021-06-30 | 88.13% | AU$15.02 Million ≈ $10.62 Million |
AU$17.04 Million ≈ $12.06 Million |
+19.89pp |
| 2020-06-30 | 68.23% | AU$4.58 Million ≈ $3.24 Million |
AU$6.72 Million ≈ $4.75 Million |
+34.23pp |
| 2019-06-30 | 34.00% | AU$763.00K ≈ $539.87K |
AU$2.24 Million ≈ $1.59 Million |
-47.88pp |
| 2018-06-30 | 81.88% | AU$12.54 Million ≈ $8.88 Million |
AU$15.32 Million ≈ $10.84 Million |
-8.90pp |
| 2017-06-30 | 90.79% | AU$22.78 Million ≈ $16.12 Million |
AU$25.09 Million ≈ $17.75 Million |
-- |
About Adherium Ltd
Adherium Limited, a digital health company, develops, manufactures, and supplies digital health technologies that address sub-optimal medication use in chronic diseases in New Zealand, Australia, Europe, and North America. The company offers Hailie Smartinhaler, a system for management of chronic respiratory conditions, including asthma and chronic obstructive pulmonary disease. It also provides … Read more